The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Research Methods · N-of-1 designs · continued

Designing a personal experiment that could change your mind — one year on posts 61–81

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

MI
m.ivaturiTL2 Moderator16 Jun 2026#61

Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you understand their contribution to the result.

0 likes 1mo
AS
a.silvaTL2 Moderator18 Jun 2026#62

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

31 likes 1mo
OC
o.cousineauTL3Regular20 Jun 2026#63
s.kimani, post #33: Picking up post #30: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the… Go to post

On post #59 — agreed on the reasoning, with one qualification.

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

11 likes in reply to #33 1mo
SF
s.ferreiraTL2 Moderator22 Jun 2026#64

Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.

3 likes 1mo
SD
s.dziedzicTL2 Moderator24 Jun 2026#65

Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what you already believed has not changed anything.

1 like 1mo
CA
c.adebayoTL2 Moderator26 Jun 2026#66

This follows post #63 rather than contradicting it.

Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met). Not deciding in advance means stopping when the result satisfies you, which is bias.

0 likes 1mo
HK
h.karlsenTL228 Jun 2026#67
DB
d.barrosTL2 Moderator30 Jun 2026#68
dr_seong, post #28: post #27 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post

Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to reach baseline. Using that washout period in a before-after design strengthens the inference.

6 likes in reply to #28 28d
JA
j.asanteTL2 Moderator2 Jul 2026#69

Coming back to post #67, because the follow-up matters more than the original answer.

Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.

3 likes 26d
TV
t.vasquezTL4 Moderator4 Jul 2026#70
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less vulnerable but not immune.

0 likes 24d
N
NardoneTL2Member6 Jul 2026#71

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

1 like 22d
LV
l.vermeulenTL2 Moderator8 Jul 2026#72

Worth separating two things that post #68 runs together.

Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.

7 likes 20d
I
IMainwaringTL3Regular10 Jul 2026#73

Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you understand their contribution to the result.

24 likes 18d
LL
l.lundgrenTL2 Moderator12 Jul 2026#74
t.abubakar, post #57: Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met). Not deciding in advance means stopping when the result satisfies you, which is bias. Go to post

Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people different from you.

0 likes in reply to #57 16d
T
TamburelloTL2Member14 Jul 2026#75

post #74 answers the question as asked. The question underneath it is different.

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

0 likes 14d
VO
v.okonkwoTL2 Moderator16 Jul 2026#76

On post #72 — agreed on the reasoning, with one qualification.

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

4 likes 12d
F
FFaulknerTL3Regular18 Jul 2026 · edited#77

Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people different from you.

17 likes 10d
HR
h.ramosTL2 Moderator20 Jul 2026#78
d.barros, post #68: Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to reach baseline. Using that washout period in a before-after design strengthens the inference. Go to post

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

0 likes in reply to #68 8d
C
CSagredoTL3Regular22 Jul 2026#79

Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.

6 likes 6d
RM
r.molnarTL2 Moderator24 Jul 2026#80

Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you understand their contribution to the result.

16 likes 4d
AS
a.silvaTL2 Moderator26 Jul 2026#81

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

4 likes 2d

Suggested topics

TopicParticipantsRepliesViewsActivity
Washout with a one-week half-life: the arithmetic — does this still hold?
Washout with a one-week half-life: the arithmetic — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
AFANABANNN+41 45 12k 1d
Pre-registering a personal experiment, seriously
Pre-registering a personal experiment, seriously — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SUSTAIN 6 ( N Engl J Med , 2016) and finding the…
PADAVSSJL+96 119 58k 14mo
Blinding yourself: practical methods and their limits — the long version
Blinding yourself: practical methods and their limits — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024)…
CTSDNGJEMD+7 11 1.8k 22h
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before…
VELIGRAC+106 118 25k 4mo
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in…
SBSKGF 2 46k 11mo

Related topics — sharing the tags effect size, data table, worked example

TopicParticipantsRepliesViewsActivity
Second pass at: Multiplicity when you track fifteen variables
Posting this under the heading it deserves: Second pass at: Multiplicity when you track fifteen variables Everything below is what sits behind that. I have seen SCALE ( N Engl J Med , 2015) cited in support…
KFFFRM 2 12k 18mo
Why cagrilintide alone is discussed so much less than in combination — does this still hold?
Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4…
SBKRSICPMN+27 31 1.2k 22h
Bioimpedance and hydration: why the number moves
Bioimpedance and hydration: why the number moves — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a method is not a…
SRANRDRVOV+62 70 13k 23d
Titrating on tolerability rather than on the calendar
On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking rather…
POCCMH 2 31k 13mo
What pooling buys you and what it destroys
The question in the title: What pooling buys you and what it destroys I will give what I have already checked below so nobody repeats it. Comparing SURMOUNT-2 ( Lancet , 2023) with LEADER ( N Engl J Med ,…
MDEHDHPMNA+74 83 6.6k 8mo